Mounjaro in Edinburgh: The Complete Guide from a Pharmacist

What is Mounjaro?

Mounjaro is the brand name for tirzepatide, a once-weekly injectable medication developed by Eli Lilly. It was originally approved for the treatment of type 2 diabetes and has since received MHRA approval in the UK as a treatment for chronic weight management in adults who meet specific clinical criteria.

Unlike older weight loss medications, Mounjaro belongs to a completely new class of drug — a dual GIP and GLP-1 receptor agonist. This dual action is what sets it apart from semaglutide-based injections (Wegovy, Ozempic) and is the main reason clinical trials have shown it to be the most effective pharmacological weight loss treatment currently available.

It comes as a pre-filled autoinjector pen — the KwikPen — which is self-administered once a week, on the same day each week, as a subcutaneous (under the skin) injection into the abdomen, thigh, or upper arm.

Mounjaro is not a quick fix. It works best as part of a structured programme that includes a reduced-calorie diet and increased physical activity, supported by ongoing clinical oversight. That is exactly what our pharmacist-led service in Edinburgh provides.

How Does Mounjaro Work? The Science in Plain English

To understand why Mounjaro is so effective, it helps to know a little about the hormones it mimics.

GLP-1: The appetite hormone

GLP-1 (glucagon-like peptide-1) is a hormone released naturally after eating. It signals to your brain that you are full, slows down gastric emptying (how quickly food leaves your stomach), and reduces appetite between meals. Mounjaro mimics GLP-1 artificially, which is why patients on the drug feel full faster, eat less, and experience fewer food cravings — even at the starter dose.

GIP: The fat-storage hormone

GIP (glucose-dependent insulinotropic polypeptide) is a lesser-known but equally important gut hormone. It plays a role in fat storage, insulin secretion, and energy balance. Mounjaro is the first medication to target both GIP and GLP-1 simultaneously, which researchers believe is why it produces substantially greater weight loss than GLP-1-only medications like semaglutide.

In simple terms: Mounjaro works on two pathways at once. You feel less hungry. Food moves through your system more slowly. Your body stores less fat. Over weeks and months, these effects compound into meaningful, sustained weight loss.

Crucially, because it also improves insulin sensitivity and reduces blood glucose, many patients see significant improvements in type 2 diabetes markers, blood pressure, and cholesterol levels as a secondary benefit of the weight loss itself.

What the Clinical Evidence Shows

Mounjaro has one of the most impressive clinical trial records of any weight loss medication ever approved. The SURMOUNT trial programme — a series of large-scale, randomised, controlled trials — provides robust evidence of its effectiveness.

SURMOUNT-1: The landmark trial

In SURMOUNT-1, 2,539 adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related condition took part over 72 weeks. Those who received the highest dose of tirzepatide (15mg) alongside lifestyle changes lost an average of 22.5% of their body weight. At the 10mg dose, average weight loss was 21.4%, and at 5mg, 16%.

To put that in perspective: for someone weighing 100kg, a 22.5% reduction represents 22.5kg of weight loss. That is broadly comparable to the results seen with bariatric surgery in some studies.

SURMOUNT-2: Patients with type 2 diabetes

SURMOUNT-2 showed that patients with type 2 diabetes — who typically respond less dramatically to weight loss interventions — still lost an average of 15.7% of their body weight at the 15mg dose. Their HbA1c (blood sugar marker) also improved substantially, with many patients reducing or stopping other diabetes medications.

Real-world context

Clinical trials represent controlled conditions. Real-world results vary. Some patients lose more, some less. Individual factors — starting weight, diet adherence, activity level, genetics, and how consistently the medication is taken — all influence outcomes. Our pharmacists will give you a realistic, honest picture of what to expect at your consultation.

Am I Eligible for Mounjaro?

Mounjaro is prescribed in line with MHRA-approved criteria for weight management. At our Edinburgh clinic, we conduct a full clinical consultation to assess your suitability. Here is a straightforward summary of the criteria.

You are likely eligible if:

• Your BMI is 30 kg/m² or above, or
• Your BMI is 27 kg/m² or above and you have at least one of the following weight-related conditions: type 2 diabetes, high blood pressure (hypertension), high cholesterol (dyslipidaemia), obstructive sleep apnoea, or cardiovascular disease
• You are committed to making dietary changes and increasing activity alongside treatment
• You have not had an allergic reaction to tirzepatide or any of its ingredients

Mounjaro may not be suitable if you:

• Have a personal or family history of medullary thyroid carcinoma (MTC)
• Have Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
• Have a history of pancreatitis
• Are pregnant, planning a pregnancy, or breastfeeding
• Have severe kidney or liver disease
• Have a history of severe gastrointestinal disease

This list is not exhaustive. During your consultation, our pharmacist will review your full medical history, current medications, and any relevant conditions to give you a personalised assessment. If Mounjaro is not right for you, we will explain why and discuss alternatives.

Your Mounjaro Journey: What to Expect Week by Week

One of the most common questions we get is: “When will I notice it working?” Here is an honest, realistic timeline based on both the clinical evidence and the experience of patients we support at our Edinburgh clinic.

Weeks 1–4: Starting at 2.5mg

Treatment always begins at the starter dose of 2.5mg. This is intentional — it lets your body adjust gradually and minimises side effects. Most patients notice a reduction in appetite and food cravings within the first week, even at this low dose. You may also feel fuller faster at mealtimes. Weight loss at this stage is modest — typically 0.5–1.5kg — because the metabolic effect is still building. Do not be discouraged. This is the foundation phase.

Weeks 5–8: Stepping up to 5mg

After four weeks, the dose increases to 5mg. This is where most patients start to notice more significant appetite suppression and early weight loss momentum. Typical weight loss by week 8 is 2–4% of starting body weight. Nausea, if it occurs, is most common in this phase as the dose increases.

Months 3–6: Building to therapeutic dose

Dose increases continue every four weeks (7.5mg, 10mg, 12.5mg) until you reach your optimal maintenance dose — either the highest dose you tolerate well, or the dose at which you are achieving satisfactory results. By month 6, many patients have lost 10–15% of their starting body weight. Energy levels typically improve. Many patients report that their relationship with food changes fundamentally — food becomes fuel rather than a source of comfort or compulsion.

Months 6–18: Sustained weight loss

Weight loss continues, though the rate typically slows as the body adapts. The goal in this phase shifts from rapid reduction to sustainable, controlled loss and the development of lasting healthy habits. Our pharmacist team provides ongoing check-ins and clinical support throughout.

After treatment: Long-term management

This is an important conversation that not everyone has before starting. The SURMOUNT-4 trial showed that patients who stopped Mounjaro regained a significant proportion of the weight they had lost within 12 months. This does not mean Mounjaro “doesn’t work” — it means, like most chronic conditions, obesity responds to ongoing treatment. We discuss long-term management openly with all patients so you go in with realistic expectations and a clear plan.

Mounjaro Doses Explained

Mounjaro comes in six doses. Treatment always follows the same stepwise escalation schedule, increasing every four weeks. Dose escalation can be paused or slowed if side effects are troublesome — this is a clinical decision made in consultation with your pharmacist, not a one-size-fits-all protocol.

Mounjaro Side Effects: What You Should Know

Being honest about side effects is part of responsible prescribing. Mounjaro is well tolerated by most patients, but it does cause side effects in some people — particularly during dose escalation phases.

Very common (affecting more than 1 in 10 patients)

• Nausea — typically mild to moderate, most common in the first few weeks after a dose increase. Usually improves within 1–2 weeks as your body adjusts.
• Diarrhoea — again, usually transient. Staying well hydrated is important.
• Decreased appetite — technically a side effect, but in this context, the intended therapeutic effect.
• Constipation — can occur as gastric motility changes. High-fibre intake and hydration help significantly.

Common (affecting 1–10 in 100 patients)

• Vomiting — usually triggered by eating too quickly or eating fatty, rich foods
• Injection site reactions — redness, swelling, or itching at the injection site
• Abdominal discomfort or bloating
• Reflux or indigestion

Rare but important

• Pancreatitis — if you experience severe, persistent abdominal pain radiating to your back, stop the injection and seek urgent medical attention
• Gallbladder disease — rapid weight loss can increase gallstone risk. Report right-sided upper abdominal pain to your pharmacist
• Hypoglycaemia — primarily a risk in patients also taking insulin or sulfonylureas for diabetes

Most patients find side effects manageable and temporary. Practical strategies — eating slowly, choosing lower-fat foods, staying hydrated, avoiding large meals — make a significant difference. Our pharmacist team will give you a detailed side effect management guide when you start treatment, and you can contact us between appointments if you have concerns.

Mounjaro vs Wegovy vs Ozempic: How Do They Compare?

Patients researching weight loss injections in Edinburgh frequently ask how Mounjaro compares to Wegovy (semaglutide 2.4mg) and Ozempic (semaglutide 1mg). Here is a straightforward comparison.

On the basis of clinical evidence, Mounjaro currently offers the greatest average weight loss of any licensed weight loss injection. That said, the right medication is the one that is clinically appropriate for you as an individual. Your pharmacist will discuss all options during your consultation.

→ Read our full comparison: Mounjaro vs Wegovy vs Ozempic

Mounjaro Cost in Edinburgh

We believe in complete price transparency. Each Mounjaro pen provides four weekly doses — one month’s supply. The cost increases as the dose escalates, reflecting the higher pen price. There are no hidden consultation fees when you book as part of our programme; the pharmacist consultation and ongoing clinical support are included.

Is Mounjaro available on the NHS?

Mounjaro has been approved by NICE for use on the NHS in England, and the Scottish Medicines Consortium (SMC) is reviewing its use in Scotland. However, NHS access is currently restricted to specialist weight management services (Tier 3 and Tier 4) and is not routinely available through GPs. For most patients in Edinburgh today, a private prescription from a pharmacist is the practical route to accessing treatment without waiting.

→ Read our full Mounjaro cost guide for Edinburgh patients

How to Get Mounjaro at Bruntsfield Pharmacy, Edinburgh

Our process is designed to be straightforward, clinically thorough, and as fast as possible — because waiting does not help anyone who needs treatment.

1. Book your consultation — online or by phone. Appointments are available within days, not weeks.
2. Complete a medical questionnaire — we will ask about your health history, current medications, weight history, and goals before your appointment so the consultation is focused and efficient.
3. Pharmacist consultation — a qualified pharmacist reviews your health information, answers your questions, confirms your eligibility, and discusses expectations, side effects, and the dose escalation plan.
4. Private prescription issued — if Mounjaro is clinically appropriate, your prescription is issued on the same day. No separate GP visit is required.
5. Start treatment — your Mounjaro pen is dispensed directly from our Edinburgh pharmacy. We will show you exactly how to use the KwikPen autoinjector before you leave.
6. Ongoing support — monthly check-ins with your pharmacist, access to our clinical team between appointments, and clear guidance at each dose escalation step.

Why Choose Bruntsfield Pharmacy for Mounjaro in Edinburgh?

Frequently Asked Questions About Mounjaro in Edinburgh

Can I get Mounjaro in Edinburgh without a GP referral?

Yes. Bruntsfield Pharmacy offers a pharmacist-led Mounjaro service. You do not need a GP referral. A private prescription is issued following a clinical consultation with one of our pharmacists, who assesses your eligibility based on MHRA-approved criteria.

How much weight can I expect to lose on Mounjaro?

Clinical trials showed an average weight loss of up to 22.5% of body weight over 72 weeks at the 15mg dose, alongside lifestyle changes. Individual results vary. Most patients see meaningful weight loss by months 2–3, with continued progress through the escalation phase.

Is Mounjaro available on the NHS in Edinburgh?

Currently, NHS access to Mounjaro in Scotland is limited to specialist weight management services. Most patients cannot access it through their GP. A private prescription from our Edinburgh pharmacy is the fastest route for most people.

How long before Mounjaro starts working?

Most patients notice reduced appetite within 1–2 weeks, even at the starter 2.5mg dose. Meaningful weight loss (1–2% of body weight) is typically visible by weeks 4–8. The full effect builds over 12–20 weeks as the dose increases.

What happens if I stop taking Mounjaro?

Clinical data from SURMOUNT-4 shows that most patients regain a significant portion of lost weight within 12 months of stopping treatment. Mounjaro treats obesity as the chronic condition it is — stopping it removes the treatment effect. Long-term management strategy is something we discuss at your consultation.

Can I take Mounjaro if I have type 2 diabetes?

Yes — Mounjaro was originally developed as a diabetes medication and is particularly effective in patients with type 2 diabetes. However, if you are already on diabetes medication (particularly insulin or sulfonylureas), dose adjustments may be required. This will be reviewed thoroughly at your consultation.

Is it safe to drink alcohol on Mounjaro?

Moderate alcohol consumption is not contraindicated with Mounjaro, but alcohol can worsen nausea — particularly in the early weeks — and contributes empty calories that work against weight loss goals. We recommend minimising alcohol during the escalation phase. If you have questions about your specific situation, ask your pharmacist.

Where can I inject Mounjaro?

Mounjaro is injected subcutaneously (under the skin) into the abdomen, thigh, or upper arm. Injection sites should be rotated each week. Full injection technique guidance is provided at your first appointment, and our team is always available if you have questions.

Learn More: Our Mounjaro Resources

• Mounjaro Cost in Edinburgh: Full Pricing Guide
• Am I Eligible for Mounjaro? BMI, Conditions and Criteria Explained
• Mounjaro vs Wegovy vs Ozempic: Which is Right for You?
• Mounjaro Side Effects: What to Expect and How to Manage Them
• Mounjaro Dosing Guide: From 2.5mg to 15mg Explained
• Weight Loss Clinic Edinburgh: Our Full Service

Last reviewed: June 2026